Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Neuropharmacology > Chapter 14: Marijuana And The Cannabinoids > Flashcards

Chapter 14: Marijuana And The Cannabinoids Flashcards

(49 cards)

Start Studying
1
Q

The psychoactive properties of marijuana result primarily from two phytocannabinoids

A

THC

Cannabidiol (CBD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

THC

A
  • inhaled or oral
  • 20-30% absorbed into lungs
  • lower bioavailability with oral consumption
  • partial agonist at CB1 receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cannabidiol

A
  • bioactive
  • low affinity- many possible targets
  • therapeutic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

[…] and […] can be added to cannabinoids

A

Terpenes and flavanoids can be added to cannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sinsemilla

A

Produced without seeds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hashish

A

Cannabis extract that can be smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

THC is metabolized by the […] and distributed in […]

A

THC is metabolized by the liver and distributed in adipose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

THC metabolites

A

11-OH-THC: metabolization occurs rapidly
- shows recent use

THC-COOH: carboxylation

     - half-life- 1 week
     - gets redistributed to other tissues, specifically adipose tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

THC Excretion

A

2/3 in feces

1/3 in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

11-OH-THC Half-life

A

20-30 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

THC Oral consumption

A

First pass metabolism reduces bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Administration of THC effects

A
  1. Reduced locomotor activity
  2. Hypothermia
  3. Catalepsy as indicated by immobility in ring test
  4. Hypoalgesia (reduced pain sensitivity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 different cannabinoid receptors

A

CB1

CB2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CB1 receptors

A
  • primary CB receptor in the CNS
  • wide distribution: cortex, basal ganglia, hippocampus, cerebellum
  • presynaptic nerve terminal
    - Gi/o, increased gk, and decreased gca
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CB2

A
  • peripheral (bone, fat, GI)
  • microglia
  • low expression in neurons
  • CB2 agonist- mediated cytokines suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Endocannabinoids are […] derivative of membrane phospholipid

A

Endocannabinoids are fatty acid derivatives of membrane phospholipid

Anandamide
2-AG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anadamide

A

Arachidonoyl ethanolamine (AEA)

  • CB1 partial agonist
  • multiple synthetic pathways
  • degraded by FAAH (fatty acid aside hydrolase)
    - very, very nonpolar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2-AG

A

2-arachidonoylglycerol

  • full agonist, non selective
  • CB1 and CB2
  • degraded by MAGL (monoacyl- glycerol lipase)
  • COX-2: enzyme that plays important role inflammation
    - COX-2 inhibitors: nonsteroidal anti-inflammatory drugs (NSAIDs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DAG lipase (DGL) converts […]

A

DAG lipase (DGL) converts DAG —> 2-AG

  • increased [Ca2+] by VGCC or NMDA-R
  • GPCR/ PLC (also PLA2 and PLD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Monoacyl- glycerol lipase (MAGL)

Study These Flashcards
A

Degrades 2-AG

21
Q

Uptake transporter

Study These Flashcards
A

Characterization is incomplete

22
Q

There are 3 different signaling mechanisms used by endocannbinoids

Study These Flashcards
A

Retrograde signaling- usual mode of altering communication
Non-retrograde signaling
- TRPV1- nonspecific cation channels (capsaicin receptor)
Neuron- Astrocytes signaling

23
Q

Retrograde signaling by endocannabinoids is involved in synaptic plasticity

Study These Flashcards
A

Homosynaptic excitatory LTD: released Glu

Heterosynaptic inhibitory LTD: released GABA

24
Q

Pharamcological and genetic techniques are used to determine the roles of CB receptors

Study These Flashcards
A

Ligands

Knock-out mice:
- CB1, CB2, FAAH, or MAGL KO

25
Pharmacological technique ligands
CP-55940 and WIN 55212-2: full agonists CB1 and CB2 SR 141716A (rinomabant): selective CB1 antagonist
26
CB1 receptors involved in brain’s reward system:
1. Reductions in rewarding effects of natural substances such as food/ sweetened solutions in animals that lack eCB activity 2. Enhanced reward due to pharmacological manipulation that increase eCB signaling
27
CB1 receptors mediate many of the effects of TNC and endocannabinoids
Resultant effects of THC in mice - decreased locomotion - hypothermia - catalepsy - hypoalgesia
28
Functional effects of cannabinoids
- decreased nausea/ vomiting - memory/ extinction (impairs episodic, verbal memory and working memory) - anxiolytic, antidepressant - analgesic - decreased seizure
29
4 stages in infrequent THC use
1. Buzz 2. High 3. Stoned 4. Come-down
30
Reinforcement
Activation of DA neurons in VTA and increased DA release to N Acc - cannabinoids activate CB1 receptors in GABAergic interneurons of VTA —> reduction in local GABA —> cell firing
31
eCB signaling is anxiolytic and antidepressant
In humans, acute cannabis produces feelings of relaxation, reduced anxiety and elevated mood - converging lines of evidence in rodents illustrate the anxiolytic and antidepressant effects of eCB signaling
32
eCB signaling is anxiolytic and antidepressant: increase eCB
- eCBs are anxiolytic in EPM, light-dark test | - inhibition of FAAH prevents anxiety-like behaviors following social defeat stress
33
eCB signaling is anxiolytic and antidepressant: decrease eCB
- CB1 KO show increased anxiety | - mice with disrupted DGLa increases both anxiety and depression
34
DGLa deletion
- reduces 2-AG in PFC, amygdala, and striatum - increases anxiety - increased anhedonia
35
There is limited evidence that cannabinoids improve symptoms of depression
No RCTs have specifically evaluated cannabis in patients with a depressive disorder - evidence is inconclusive
36
There is limited evidence that cannabinoids improve symptoms of anxiety
- only 1 RCT with high risk of bias (small N) found greater improvement with CBD on a stimulated public speaking test - 4 other RCTs examined anxiety symptoms in patients with chronic pain- 3 judged to have high risk of bias
37
Hyperalgesia is induced by:
CB1R or CB2R KO or chronic CB1R antagonist SR141716A Analgesic mechanisms - inhibition of transmitter and peptide release - modulation of postsynaptic neuron excitability - activation of descending inhibitory pain pathway - reduction of neural inflammation
38
Cannabinoids affect the cognitive aspects of pain
mGluR5 in mPFC - PLC—>DAG—>DAGLa—> 2-AG synthesis 2-AG activated presynaptic CB1 - decreased GABA release, mPFC in disinhibited - driving inhibitory neurons in the amygdala
39
There is substantial evidence that cannabis is an effective treatment for chronic pain in adults
RCTs that compared cannabinoids to usual care, a placebo, or no treatment for 10 pain conditions - OR of reporting 30% or greater reduction of pain
40
The first FDA- approved drug that contains a purified drug substance derived from marijuana
Epidiolex - Lennox-Gastaut syndrome - Dravet syndrome
41
The addiction potential of THC
- humans and squirrel monkeys self-administer THC | - rodents and Theseus monkeys do NOT
42
THC self-administration: role of CB1
- blocked by SR141716A | - 2-AG is also self-administered
43
Cannabinoids are atypical drugs of abuse
Self- administration - only under certain conditions - eg. Pre-exposed to drug, food, or H2O deprived, etc Conditioned place preference Threshold of ICSS - CBS are reinforcing under the appropriate experimental conditions and choice of species
44
Amotivational Syndrome
State of relaxed and careless drifting after significant marijuana use
45
Cannabinoids act on CB1 receptors on GABAergic interneurons in the VTA to inhibit GABA release
CB1-R in VTA - hyperpolarize IN - decrease GABA release - increase VTA firing - increase DA release
46
CB1 and MOP receptors seem to work together
MOR in VTA - increased DA release - CBS lose rewarding properties in MOR-KO
47
Chronic CB administration leads to tolerance and precedes precipitated withdrawal: Tolerance
- CB1 desensitization | - CB1 down-regulation
48
Chronic CB administration leads to tolerance and precedes precipitated withdrawal: Withdrawal
- Precipitated with SR 141716A - decreased DA neuron firing - increased CRF release in CeA - increased stress hormones (ex. Corticosterone)
49
Precipitated Withdrawal
Administration of antagonist would abruptly block receptors despite continued presence of THC

Neuropharmacology (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions